T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLOX
1301
DELISTED
Infoblox Inc
BLOX
| $11.4M | ﹤0.01% |
476,860
+6,590
| +1% | +$142K |
|
1302
Jefferies Financial Group
JEF
$12.9B
| $11.2M | ﹤0.01% |
562,243
-13,825
| -2% | -$286K |
|
|
NAME
1303
DELISTED
Rightside Group, Ltd.
NAME
| $11.2M | ﹤0.01% |
1,099,490
+11,870
| +1% | +$91.6K |
|
1304
RE/MAX Holdings
RMAX
$265M
| $11.1M | ﹤0.01% |
335,420
+2,390
| +0.7% | +$81.5K |
|
1305
Aspen Aerogels
ASPN
$504M
| $11.1M | ﹤0.01% |
1,524,930
+117,010
| +8% | +$886K |
|
|
GAS
1306
DELISTED
AGL Resources Inc
GAS
| $11.1M | ﹤0.01% |
223,006
+3,990
| +2% | +$207K |
|
|
EXAS
1307
DELISTED
Exact Sciences
EXAS
| $11M | ﹤0.01% |
500,600
+3,000
| +0.6% | +$76.1K |
|
|
CPLA
1308
DELISTED
Capella Education Company
CPLA
| $11M | ﹤0.01% |
169,800
+64,263
| +61% | +$4.34M |
|
|
ECHO
1309
EchoStar
ECHO
$26.6B
| $11M | ﹤0.01% |
262,378
-1,111
| -0.4% | -$47.3K |
|
1310
Diageo
DEO
$52.8B
| $11M | ﹤0.01% |
99,285
+2,170
| +2% | +$250K |
|
1311
Simmons First National
SFNC
$3.46B
| $10.9M | ﹤0.01% |
479,160
+469,160
| +4,692% | +$9.55M |
|
1312
iShares Russell 2000 Value ETF
IWN
$14.7B
| $10.9M | ﹤0.01% |
105,460
+1,450
| +1% | +$146K |
|
1313
Eldorado Gold
EGO
$10B
| $10.9M | ﹤0.01% |
474,212
-860,120
| -64% | -$23.6M |
|
|
ACOR
1314
DELISTED
Acorda Therapeutics
ACOR
| $10.9M | ﹤0.01% |
2,722
+134
| +5% | +$614K |
|
1315
Immunic
IMUX
$226M
| $10.8M | ﹤0.01% |
+1,076
| New | +$9.89M |
|
|
RSPP
1316
DELISTED
RSP Permian, Inc.
RSPP
| $10.7M | ﹤0.01% |
426,540
-10,740
| -2% | -$287K |
|
|
TMX
1317
DELISTED
Terminix Global Holdings, Inc.
TMX
| $10.7M | ﹤0.01% |
+475,222
| New | +$10M |
|
|
RTI
1318
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $10.7M | ﹤0.01% |
298,890
-101,412
| -25% | -$2.84M |
|
|
POLY
1319
DELISTED
Plantronics, Inc.
POLY
| $10.6M | ﹤0.01% |
200,950
+2,400
| +1% | +$123K |
|
1320
Ziff Davis
ZD
$1.92B
| $10.6M | ﹤0.01% |
186,070
+1,380
| +0.7% | +$76.8K |
|
|
RKT
1321
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $10.6M | ﹤0.01% |
164,428
-520
| -0.3% | -$34.1K |
|
|
TSS
1322
DELISTED
Total System Services, Inc.
TSS
| $10.6M | ﹤0.01% |
277,278
+5,500
| +2% | +$201K |
|
1323
Winmark
WINA
$1.26B
| $10.5M | ﹤0.01% |
119,700
+28,458
| +31% | +$2.34M |
|
|
TVTY
1324
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $10.5M | ﹤0.01% |
531,880
-69,950
| -12% | -$1.46M |
|
1325
Teradata
TDC
$2.57B
| $10.5M | ﹤0.01% |
237,361
-5
| -0% | -$219 |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.